Archit Gupta | Associate Partner
ZS Associates
Archit Gupta is an Associate Partner at ZS and leads the firm's European Patient and Digital Care Pathways practice. Based in Zurich, he is ZS's firm-wide expert in patient engagement and care pathway innovation, advising global biopharma clients on scalable, compliant, and impactful solutions across US and ex-US markets. His work addresses the spectrum of challenges biopharma faces in activating patients: from understanding barriers and designing engagement strategy, to building and deploying digital solutions that close care pathway gaps. He has launched multiple programs across rare and specialty disease areas - including neuromuscular, cell & gene therapy, immunology, and nephrology - that have meaningfully accelerated patients' paths to diagnosis and treatment. Archit holds an MBA from the Kellogg School of Management at Northwestern University and a Bachelor's in Electronics Engineering from Thapar Institute of Engineering & Technology.
Appearances:
Day 1 - World Orphan Drug Congress USA 2026 @ 13:40
Working Group 5: Getting the details right on direct-to-patient: the 5 truths
Direct‑to‑patient strategies are moving fast—but many fail not because of ambition, but because critical details are missed. In this interactive working session, ZS experts unpack the five foundational truths that determine whether a direct-to-patient (DTP) strategy is set up for real, sustainable impact. Participants will explore how successful DTP strategies require all five elements working together: experience design, clinical design, legal design, user acquisition, and impact measurement. The session, through interactive multidisciplinary Q&A is designed to move beyond theory and provide a practical lens that participants can use to evaluate, design, and refine DTP initiatives in their own rare disease launches.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events